English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Studies Were Undertaken To Examine The Action Of S-Paf On Mammalian Platelets And Its Modification By A Variety Of Agents Known To Alter Platelet Aggregation. Racemic S-Paf Aggregated Washed Platelets Of Dogs, Humans, Rabbits And Guinea Pigs But Not Rats With Ec50 Values In The Nm And Sub-Nm Range. Albumin Was Necessary For The Stabilization Of Dilute Stock Solutions Of S-Paf But, Above 0.3% Final Concentration, Inhibition Of The Response Was Noted. In Prp, The Activity Of S-Paf Was Reduced Further To About 1/10 The Activity Seen In Buffered Solutions. Using Canine Platelets For Most Of The Remaining Studies It Was Noted That The Activity Of The S-Paf Resided In The Natural R Isomer. The Action Of S-Paf On Washed Platelets Could Be Inhibited By Camp Phosphodiesterase Inhibitors, Ibmx And Ro 20-1724, To The Extent Of 100% And 30%, Respectively, At 100 μM. The Activator Of Adenylate Cyclase, Pge1, Also Inhibited The S-Paf Effect Completely But With As Little As 1 μM. Colchicine, However, Was Inactive. Surprisingly, The Lipoxygenase (Lo) Inhibitors Etya (5,8,11,14-Eicoso- Tetraynoic Acid) And Ndga (Nordihydroguaiaretic Acid) At 100 μM Completely Blocked S-Paf Action While The Cyclooxygenase (Co) Inhibitor, Indomethacin, At The Same Concentration Reduced It By Only 50%. The Effect Of The Lo Inhibitors Was Reduced In 0.3% Albumin And Completely Prevented In Prp. The Action Of The Co Inhibitor, Indomethacin, Was Not Altered By The Presence Of Protein. Although The Action Of Indomethacin On S-Paf Disappeared At 10 μM, It Still Completely Blocked The Effects Of Arachidonic Acid (Aa) In Prp. Taken Collectively, These Data Suggest That S-Paf Can Be Blocked By Agents Which Are Able To Elevate Camp Or Inhibit The Lo Pathway Of Aa Metabolism.

thrombosis and haemostasis

The Effect Of A Completely Synthesized Platelet-Activating Factor (S-PAF), 1-0-Octadecyl-2-Acetyl-Sn-Glyceryl-3-Phos-Phorylcholine, On Mammalian Platelets